The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma
Abstract
CONTEXT: Adrenocortical carcinomas are uncommon, and their evaluation by [(18)F]fluorodeoxyglucose positron emission tomography (FDG PET) has not been well evaluated. OBJECTIVE: The purpose of this study was to examine the potential utility of FDG PET in the detection of recurrent or metastatic adrenocortical carcinoma. DESIGN: In patients with known adrenocortical carcinoma who underwent FDG-PET imaging for suspected recurrence or metastasis, FDG activity was compared with other imaging findings, clinical features, and the presence or absence of disease as confirmed by resection, biopsy, or clinical follow-up. SETTING: The study took place at four tertiary referral centers. PATIENTS OR OTHER PARTICIPANTS: Twelve patients (10 females and two males, 5-71 yr of age) were evaluated. MAIN OUTCOME MEASURES: The main outcome measures were FDG activity, other imaging findings, and clinical features. RESULTS: Abnormal FDG uptake correctly indicated tumor recurrence in 10 patients. One patient with no abnormal FDG activity had a morphological abnormality subsequently proven to be a postoperative scar. Two patients, one with very small pulmonary lesions and one with a hepatic metastasis, had false-negative findings. CONCLUSIONS: Most adrenocortical carcinomas accumulate and retain FDG and thus can be visualized by PET. However, false-negative findings are possible, especially with very small lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensity of FDG uptake was found to be related to survival in patients with ACC, with a maximum SUV of >10 indicating poor prognosis (111).”
From Adrenocortical carcinoma (2014) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
CT time-attenuation washout curves of adrenal adenomas and nonadenomas
Korobkin, M., Brodeur, F. J., Francis, I. R., Quint, L. E., Dunnick, N. R., & Londy, F. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.3.9490968 · Cited by 386
Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
KOROBKIN, M. T., Brodeur, F. J., Yutzy, G. G., Francis, I. R., Quint, L. E., Dunnick, N. R., & Kazerooni, E. A. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.166.3.8623622 · Cited by 364
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun, M., Kim, W., Alnafisi, N., Lacorte, L., Jang, S., & Alavi, A. A. (2001) · PubMed · Cited by 336
Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
Mitchell, D. G., Crovello, M., Matteucci, T., Petersen, R. O., & Miettinen, M. (1992) · Radiology · doi:10.1148/radiology.185.2.1410337 · Cited by 333
Erasmus, J. J., Patz, E. F., McAdams, H. P., Murray, J. G., Herndon, J. E., Coleman, R. E., & Goodman, P. C. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.5.9129444 · Cited by 330
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy- d -glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 303
Boland, G. W., Goldberg, M. A., Lee, M. J., Mayo-Smith, W. W., Dixon, J., McNicholas, M. M. J., & Müeller, P. R. (1995) · Radiology · doi:10.1148/radiology.194.1.7997539 · Cited by 222
Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
Szolar, D. H., & Kammerhuber, F. (1998) · Radiology · doi:10.1148/radiology.207.2.9577483 · Cited by 218
Leboulleux, S., Dromain, C., Bonniaud, G., Auperin, A., Caillou, B., Lumbroso, J., Sigal, R., Baudin, É., & Schlumberger, M. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1540 · Cited by 169
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions
Maurea, S., Mainolfi, C., Bazzicalupo, L., Panico, M. R., Imparato, C., Alfano, B., Ziviello, M., & Salvatore, M. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.1.10397094 · Cited by 159
11C-Metomidate PET imaging of adrenocortical cancer
Khan, T. S., Sundin, A., Juhlin, C., Långström, B., Bergström, M., & Eriksson, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1025-9 · Cited by 107
FDG-PET in Adrenocortical Carcinoma
Becherer, A., Vierhapper, H., Pötzi, C., Karanikas, G., Kurtaran, A., Schmaljohann, J., Staudenherz, A., Dudczak, R., & Kletter, K. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753131363 · Cited by 102
Henry, I., Jeanpierre, M., Couillin, P., Barichard, F., Serre, J., Journel, H., Lamouroux, A., TURLEAU, C., GROUCHY, J. D., & Junien, C. (1989) · Human Genetics · doi:10.1007/bf00279003 · Cited by 100
Zettinig, G., Mitterhauser, M., Wadsak, W., Becherer, A., Pirich, C., Vierhapper, H., Niederle, B., Dudczak, R., & Kletter, K. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1575-0 · Cited by 98
Sameshima, Y., Tsunematsu, Y., Watanabe, S., Tsukamoto, T., Kawa‐Ha, K., Hirata, Y., Mizoguchi, H., Sugimura, T., Terada, M., & Yokota, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.9.703 · Cited by 91
Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri, B., Maurer, A. H., Cone, L., Doss, M., & Adler, L. P. (2004) · PubMed · Cited by 82
Tenenbaum, F., Groussin, L., Foehrenbach, H., Tissier, F., Gouya, H., Bertherat, J. Y., Dousset, B. E., Legmann, P., Richard, B., & BERTAGNA, X. Y. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500789 · Cited by 59
Rao, S. K., Caride, V. J., Ponn, R. B., Giakovis, E., & Lee, S. H. (2004) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000124008.68606.4c · Cited by 42
The use of FDG-PET and CT for the staging of adrenocortical carcinoma in children
Kreissig, R., Amthauer, H., Krude, H., Steinmueller, P., Stroszczynski, C., Hosten, N., Grueters, A., & Felix, R. (2000) · Pediatric Radiology · doi:10.1007/s002470050745 · Cited by 17
Whole-Body Positron Emission Tomographic Scanning in Patients with Adrenal Cortical Carcinoma
Ahmed, M., Al‐Sugair, A., Alarifi, A., Almahfouz, A., & Al-Sobhi, S. S. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000067512.53644.fb · Cited by 16
Smoking and adrenal cancer mortality among United States veterans.
Chow, W.-H., Hsing, A. W., McLaughlin, J. K., & Fraumeni, J. F. (1996) · PubMed · Cited by 14
Hsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
King (1979) · doi:10.1002/1097-0142(197907)44:1
Wooten (1993) · doi:10.1002/1097-0142(19931201)72:11
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Sorted by citations
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Update in Adrenocortical Carcinoma
Faßnacht, M., Kroiß, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Metadata
- Authors
- Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., Hurwitz, C. A., & Schteingart, D. E.
- Affiliations
- University of Michigan (US)
- St. Jude Children's Research Hospital (US)
- Department of Internal Medicine, Divisions of Hematology-Oncology (F.P.W.) Ann Arbor, Michigan 48109
- Department of Surgery (P.G.G.) Ann Arbor, Michigan 48109
- Boston Children's Hospital (US)
- Departments of Pediatrics (G.K.) St. Louis, Missouri 63110
- Hematology-Oncology (R.C.R., C.R.-G.), St. Jude Children’s Research Hospital, Memphis, Tennessee 38105
- Washington University in St. Louis (US)
- Maine Medical Center (US)
- Endocrinology and Metabolism (D.E.S.) Ann Arbor, Michigan 48109
- Corresponding author
- Shulkin, Barry L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 91
- Issue
- 7
- Pages
- 2665-2671
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2146827226
- Cited by
- 115
- References
- 29
- Citations by year
- 2024: 5 · 2023: 6 · 2022: 9 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 6 · 2012: 8
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lebanese Syrian Associated Charities
- U.S. Public Health Service
- National Cancer Institute (5R25 CA 23944, CA54216, CA21765, R25CA023944, P30CA021765)
- National Center for Research Resources (M-01RR00042, M01RR000042)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenocortical carcinoma, FDG-PET, tumor recurrence, metastasis detection, false-negative results, small pulmonary lesions, liver metastasis, postoperative scar
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Aged, Child, Child, Preschool, False Negative Reactions, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review